Dr. Dave Anderson, Chief Scientific Officer at VBI Vaccines discusses the company's work to develop a pan-coronavirus vaccine to address mutations. He talks about the public health implications of a mutation of COVID-19. In addition to COVID, VBI Vaccines is in late-stage development of the only potential vaccine that mimics all three surface antigens of the hepatitis B virus.
#VBIVaccines #COVID19 #VACCINE
Visit our website
www.healtprofessionalradio.com.au
Follow us on our social media channels
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Google+: [ Ссылка ]...
Pinterest: [ Ссылка ]...
Linkedin: [ Ссылка ]...
Instagram: [ Ссылка ]...
Subscribe to our podcast channels
Soundcloud: [ Ссылка ]...
Itunes: [ Ссылка ]...
Support us on Patreon
[ Ссылка ]
